MyChesCo on MSN1d
Palvella Therapeutics and Pieris Pharmaceuticals Finalize Merger to Focus on Rare Disease Treatments
WAYNE, PA — Palvella Therapeutics, Inc. has completed its merger with Pieris Pharmaceuticals, Inc., forming a unified company ...
Palvella Therapeutics Announces Closing of Merger with Pieris Pharmaceuticals and Concurrent Private Placement of $78.9 Million
Palvella Therapeutics to debut on Nasdaq under the ticker symbol “PVLA” as a publicly traded rare disease biopharmaceutical company ...
Concord Biotech invests $10 lakh in Palvella Therapeutics
Concord Biotech Ltd on Thursday said it has invested USD 10 lakh (nearly Rs 85 crore) in US-based Palvella Therapeutics, Inc ...
Eagle-Tribune1mon
Palvella Therapeutics Announces First Patient Dosed in SELVA Phase 3 Clinical Trial of QTORIN™
Nov. 07, 2024 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients ...
Pieris Pharmaceuticals Announces Merger and Share Increase
Pieris Pharmaceuticals ( (PIRS) ) has shared an announcement.
money.rediff4d
Concord Biotech Invests in Palvella Therapeutics for Rare Skin Disease Drug
Concord Biotech invests USD 10 lakh in Palvella Therapeutics to manufacture and commercialize 'Qtorin', a drug for rare genetic skin diseases. The investment will strengthen their partnership and ...
Yle12d
Tuomo Pirttimaan kolumni: Olisin halunnut palvella sellaisessa armeijassa, josta lapseni kertoo inttijuttunsa
Inhoan maailmaa joka pakottaa maanpuolustustahdon esiin lapseni sukupolvesta. Ihailen että heissä sitä on, Pirttimaa ...